LIDOCAINE HYDROCHLORIDE ANHYDROUS - Food and Drug Administration
- Manufacturer
- Food and Drug Administration
- Effective date
- 2018-06-19
- Label type
- Indexing - product concept
- Version
- 4
- Source
- full-release
- Hydrated at
- 2026-06-05 00:17:39
Label at a glance#
ProductLIDOCAINE HYDROCHLORIDE ANHYDROUS
Active ingredientLIDOCAINE HYDROCHLORIDE ANHYDROUS, EPINEPHRINE BITARTRATE
Products#
Every source-derived product name is available through these pages.
- LIDOCAINE HYDROCHLORIDE ANHYDROUS
- LIDOCAINE
- EPINEPHRINE BITARTRATE
- EPINEPHRINE
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| AKTEN | LIDOCAINE HYDROCHLORIDE ANHYDROUS | Thea Pharma Inc. | 70ff9fb7-d323-4fe6-b1b1-6033e05f0749 | 2026-04-23 | Warnings, Adverse reactions | LIDOCAINE HYDROCHLORIDE ANHYDROUS |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE ANHYDROUS | Sportpharm LLC | def640dd-bce2-4c18-9ee1-4a1cd5852e89 | 2026-03-20 | Warnings, Adverse reactions | LIDOCAINE HYDROCHLORIDE ANHYDROUS |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE ANHYDROUS | Henry Schein, Inc. | bb53bb10-bb36-4c9b-b632-71455615f9f3 | 2025-09-29 | Warnings, Adverse reactions | LIDOCAINE HYDROCHLORIDE ANHYDROUS |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE ANHYDROUS | Henry Schein, Inc. | a5d4b206-cc53-470f-9bca-abfc6ea5cc99 | 2025-09-29 | Warnings, Adverse reactions | LIDOCAINE HYDROCHLORIDE ANHYDROUS |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE ANHYDROUS | Spectra Medical Devices, LLC | e8ba012a-08a9-4f67-9f88-3284377e80be | 2024-01-12 | Warnings, Adverse reactions | LIDOCAINE HYDROCHLORIDE ANHYDROUS |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.